MiniMed Infusion From Medtronic Is November Tonic For Company's Stock
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's $30 mil. equity investment in infusion systems developer MiniMed in early November, which appears to set the stage for an outright acquisition, helped spark a 28.4% monthly price gain in MiniMed stock; the issue closed at 71-1/4, up 15-3/4.